Inside this issueCover storiesA continuous infusion of philanthropyNew Cancer Center head: ‘aspire to cure cancers’Alpern reappointed to new term as dean of medical school
PeopleLifelines: Jorge GalánExpert on spinal cord injury receives VA's highest scientific awardDean of Public Health is Anna M.R. Lauder ProfessorBerliner Professor envisions blood vessel growth as therapyExpert on kidney development, repair is named Long ProfressorFive medical school faculty are elected to a venerable groupOut & aboutScienceA protein's surprise role in Alzheimer'sHow membranes get the bendsAdvances: Living dangerously, in more ways than one | A new syndrome, a new role for a geneHealthAdvances: Relax—for your heart's sake | Drug can curb both smoking and drinkingPartnershipsGrants & contractsSupporting medical education  
Download this issue in PDF format |
|
Berliner Professor envisions
|
|||
Michael Simons |
Michael Simons, M.D., recently appointed the Robert W. Berliner Professor of Medicine, is a leading researcher on angiogenesis—the growth of new blood vessels—in cardiovascular diseases.
Simons came to Yale in 2008 as chief of the Department of Internal
Medicine’s Section of Cardiovascular Medicine at the School of Medicine
and Yale-New Haven Hospital.
His research interests include fibroblast growth factor signaling in
the vascular system, regulation of arterial development and branching,
and endothelial signaling. He is developing strategies to deliver and
assess various biological agents—genes, proteins, antibodies, and
receptor “traps”—and in identifying and validating novel biomarkers
that predict individual responses to therapies. He has been an advocate
for using biological therapies to stimulate new vessel growth to
improve circulation in damaged regions of the heart or in
blood-deprived limbs.
Before coming to Yale, Simons was the A.G. Huber Professor of Medicine, and professor of pharmacology and toxicology, at Dartmouth Medical School. He was also chief of cardiology at Dartmouth-Hitchcock Medical Center and the director of its Cardiovascular Center.
Simons received his M.D. from Yale in 1984. He was a resident in
internal medicine at New England Medical Center, Boston, and a medical
staff fellow and postdoctoral fellow at the National Heart, Lung and
Blood Institute at the National Institutes of Health. He completed a
fellowship in cardiology at Beth Israel Hospital in Boston and
postdoctoral training at Massachusetts Institute of Technology, where
he was an associate scientist in the Program for Excellence in
Molecular Biology of the Cardiovascular System. 
